COLAZAL(R) Pediatric Exclusivity Filing Submitted (Business Wire via Yahoo! Finance)
RALEIGH, N.C.----July 5, 2006--Salix Pharmaceuticals, Ltd. today announced that the Company submitted on June 20, 2006 what it believes to be a complete response to a Written Request received from the U.S.

Salix Expands XIFAXAN(R) Intellectual Property (Business Wire via Yahoo! Finance)
RALEIGH, N.C.----July 5, 2006--Salix Pharmaceuticals, Ltd. today announced that the Company has entered into an agreement with Cedars-Sinai Medical Center, or CSMC, for the right to use U.S.

CSMC grants rights over rifaximin to Salix (PharmaBiz)
Salix Pharmaceuticals, Ltd. announced that the company has entered into an agreement with Cedars-Sinai Medical Center, (CSMC), for the right to use US Patent No. 6,861,053 and US Patent Application No. 11/234,516 relating to methods of diagnosis and treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth.